Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Specific immune cell and lymphatic vessel signatures identified by image analysis in renal cancer.

Schraml P, Athelogou M, Hermanns T, Huss R, Moch H.

Mod Pathol. 2019 Jul;32(7):1042-1052. doi: 10.1038/s41379-019-0214-z. Epub 2019 Feb 8.

PMID:
30737470
2.

Dealing with context in logic model development: Reflections from a realist evaluation of a community health worker programme in Nigeria.

Ebenso B, Manzano A, Uzochukwu B, Etiaba E, Huss R, Ensor T, Newell J, Onwujekwe O, Ezumah N, Hicks J, Mirzoev T.

Eval Program Plann. 2019 Apr;73:97-110. doi: 10.1016/j.evalprogplan.2018.12.002. Epub 2018 Dec 7.

3.

Synthesis of next generation dual-responsive cross-linked nanoparticles and their application to anti-cancer drug delivery.

Schwarzenböck C, Nelson PJ, Huss R, Rieger B.

Nanoscale. 2018 Aug 30;10(34):16062-16068. doi: 10.1039/c8nr04760j.

PMID:
30109346
4.

New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression.

Gullo I, Oliveira P, Athelogou M, Gonçalves G, Pinto ML, Carvalho J, Valente A, Pinheiro H, Andrade S, Almeida GM, Huss R, Das K, Tan P, Machado JC, Oliveira C, Carneiro F.

Gastric Cancer. 2019 Jan;22(1):77-90. doi: 10.1007/s10120-018-0836-8. Epub 2018 May 19.

PMID:
29779068
5.

Strengthening health district management competencies in Ghana, Tanzania and Uganda: lessons from using action research to improve health workforce performance.

Martineau T, Raven J, Aikins M, Alonso-Garbayo A, Baine S, Huss R, Maluka S, Wyss K.

BMJ Glob Health. 2018 Apr 9;3(2):e000619. doi: 10.1136/bmjgh-2017-000619. eCollection 2018.

6.

Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer.

Harder N, Athelogou M, Hessel H, Brieu N, Yigitsoy M, Zimmermann J, Baatz M, Buchner A, Stief CG, Kirchner T, Binnig G, Schmidt G, Huss R.

Sci Rep. 2018 Mar 13;8(1):4470. doi: 10.1038/s41598-018-22564-7.

7.

Fluorescent Polyvinylphosphonate Bioconjugates for Selective Cellular Delivery.

Schwarzenböck C, Schaffer A, Nößner E, Nelson PJ, Huss R, Rieger B.

Chemistry. 2018 Feb 21;24(11):2584-2587. doi: 10.1002/chem.201706034. Epub 2018 Jan 25.

PMID:
29315897
8.

Women's experiences of routine care during labour and childbirth and the influence of medicalisation: A qualitative study from Iran.

Pazandeh F, Potrata B, Huss R, Hirst J, House A.

Midwifery. 2017 Oct;53:63-70. doi: 10.1016/j.midw.2017.07.001. Epub 2017 Jul 14.

9.

Mesenchymal Stromal Cells Protect Endothelial Cells from Cytotoxic T Lymphocyte-Induced Lysis.

Cahill EF, Sax T, Hartmann I, Haffner S, Holler E, Holler B, Huss R, Günther C, Parolini O, Kolch W, Eissner G.

Scand J Immunol. 2016 Sep;84(3):158-64. doi: 10.1111/sji.12459.

10.

Study protocol: realist evaluation of effectiveness and sustainability of a community health workers programme in improving maternal and child health in Nigeria.

Mirzoev T, Etiaba E, Ebenso B, Uzochukwu B, Manzano A, Onwujekwe O, Huss R, Ezumah N, Hicks JP, Newell J, Ensor T.

Implement Sci. 2016 Jun 7;11(1):83. doi: 10.1186/s13012-016-0443-1.

11.

An evaluation of the quality of care for women with low risk pregnanacy: The use of evidence-based practice during labour and childbirth in four public hospitals in Tehran.

Pazandeh F, Huss R, Hirst J, House A, Baghban AA.

Midwifery. 2015 Nov;31(11):1045-53. doi: 10.1016/j.midw.2015.07.003. Epub 2015 Jul 14.

PMID:
26292760
12.

Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial.

Niess H, von Einem JC, Thomas MN, Michl M, Angele MK, Huss R, Günther C, Nelson PJ, Bruns CJ, Heinemann V.

BMC Cancer. 2015 Apr 8;15:237. doi: 10.1186/s12885-015-1241-x.

13.

Quantification of in vitro mesenchymal stem cell invasion into tumor spheroids using selective plane illumination microscopy.

Rühland S, Wechselberger A, Spitzweg C, Huss R, Nelson PJ, Harz H.

J Biomed Opt. 2015 Apr;20(4):040501. doi: 10.1117/1.JBO.20.4.040501.

PMID:
25839427
14.

Modulation of mesenchymal stromal cell characteristics by microcarrier culture in bioreactors.

Hupfeld J, Gorr IH, Schwald C, Beaucamp N, Wiechmann K, Kuentzer K, Huss R, Rieger B, Neubauer M, Wegmeyer H.

Biotechnol Bioeng. 2014 Nov;111(11):2290-302. doi: 10.1002/bit.25281. Epub 2014 Jul 14.

PMID:
24890974
15.

Bone marrow-derived mesenchymal stem cells migrate to healthy and damaged salivary glands following stem cell infusion.

Schwarz S, Huss R, Schulz-Siegmund M, Vogel B, Brandau S, Lang S, Rotter N.

Int J Oral Sci. 2014 Sep;6(3):154-61. doi: 10.1038/ijos.2014.23. Epub 2014 May 9.

16.

Can action research strengthen district health management and improve health workforce performance? A research protocol.

Mshelia C, Huss R, Mirzoev T, Elsey H, Baine SO, Aikins M, Kamuzora P, Bosch-Capblanch X, Raven J, Wyss K, Green A, Martineau T.

BMJ Open. 2013 Aug 30;3(8):e003625. doi: 10.1136/bmjopen-2013-003625.

17.

Mesenchymal stromal cell characteristics vary depending on their origin.

Wegmeyer H, Bröske AM, Leddin M, Kuentzer K, Nisslbeck AK, Hupfeld J, Wiechmann K, Kuhlen J, von Schwerin C, Stein C, Knothe S, Funk J, Huss R, Neubauer M.

Stem Cells Dev. 2013 Oct 1;22(19):2606-18. doi: 10.1089/scd.2013.0016. Epub 2013 Jun 22.

18.

Heat stress management program improving worker health and operational effectiveness: a case study.

Huss RG, Skelton SB, Alvis KL, Shane LA.

Workplace Health Saf. 2013 Mar;61(3):128-33; quiz 134. doi: 10.3928/21650799-20130218-38. Epub 2013 Feb 25.

PMID:
23429639
19.

Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer.

Bao Q, Zhao Y, Niess H, Conrad C, Schwarz B, Jauch KW, Huss R, Nelson PJ, Bruns CJ.

Stem Cells Dev. 2012 Sep 1;21(13):2355-63. doi: 10.1089/scd.2012.0060. Epub 2012 Jun 26. Review.

20.

APC/C(Cdh1)-mediated degradation of the F-box protein NIPA is regulated by its association with Skp1.

Klitzing Cv, Huss R, Illert AL, Fröschl A, Wötzel S, Peschel C, Bassermann F, Duyster J.

PLoS One. 2011;6(12):e28998. doi: 10.1371/journal.pone.0028998. Epub 2011 Dec 20.

21.

The value of HAZWOPER medical surveillance.

Huss RG, Williamson KN, Alvis KL, Hewitt DJ.

AAOHN J. 2011 Nov;59(11):465-7. doi: 10.3928/08910162-20111025-03.

PMID:
22045009
22.

Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.

Niess H, Bao Q, Conrad C, Zischek C, Notohamiprodjo M, Schwab F, Schwarz B, Huss R, Jauch KW, Nelson PJ, Bruns CJ.

Ann Surg. 2011 Nov;254(5):767-74; discussion 774-5. doi: 10.1097/SLA.0b013e3182368c4f.

PMID:
22042469
23.

Spindle Cell Metaplastic Breast Carcinoma with Leiomyoid Differentiation: A Case Report.

Conrad C, Miller DL, Kaiser C, Jauch KW, Nieß H, Huss R.

Breast Care (Basel). 2011;6(3):230-233. Epub 2011 Jun 14.

24.

Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis.

Conrad C, Hüsemann Y, Niess H, von Luettichau I, Huss R, Bauer C, Jauch KW, Klein CA, Bruns C, Nelson PJ.

Ann Surg. 2011 Mar;253(3):566-71. doi: 10.1097/SLA.0b013e3181fcb5d8.

PMID:
21169810
25.

Good governance and corruption in the health sector: lessons from the Karnataka experience.

Huss R, Green A, Sudarshan H, Karpagam S, Ramani K, Tomson G, Gerein N.

Health Policy Plan. 2011 Nov;26(6):471-84. doi: 10.1093/heapol/czq080. Epub 2010 Dec 17.

26.

A changing time: the International Society for Cellular Therapy embraces its industry members.

Deans R, Gunter KC, Allsopp T, Bonyhadi M, Burger SR, Carpenter M, Clark T, Cox CS, Driscoll D, Field E, Huss R, Lardenoije R, Lodie TA, Mason C, Neubiser R, Rasko JE, Rowley J, Maziarz RT.

Cytotherapy. 2010 Nov;12(7):853-6. doi: 10.3109/14653249.2010.523958.

PMID:
20942603
27.

Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation.

Huss RS, Huddleston JI, Goodman SB, Butcher EC, Zabel BA.

Arthritis Rheum. 2010 Dec;62(12):3799-805. doi: 10.1002/art.27751.

28.

Suppression of parasitic oscillations in a core-doped ceramic Nd:YAG laser by Sm:YAG cladding.

Huss R, Wilhelm R, Kolleck C, Neumann J, Kracht D.

Opt Express. 2010 Jun 7;18(12):13094-101. doi: 10.1364/OE.18.013094.

PMID:
20588439
29.

Stem cell therapeutics: hope for patients and biopharma!

Huss R.

Stem Cells Dev. 2010 May;19(5):593-4. doi: 10.1089/scd.2010.1500. No abstract available.

PMID:
20491562
30.

Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma.

Zischek C, Niess H, Ischenko I, Conrad C, Huss R, Jauch KW, Nelson PJ, Bruns C.

Ann Surg. 2009 Nov;250(5):747-53. doi: 10.1097/SLA.0b013e3181bd62d0. Erratum in: Ann Surg. 2010 Jan;251(1):187.

PMID:
19826249
31.

[Molecular diagnostics and imaging].

Fink C, Fisseler-Eckhoff A, Huss R, Nestle U.

Onkologie. 2009;32 Suppl 1:3-8. doi: 10.1159/000215715. Epub 2009 Jun 10. Review. German.

32.

Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo.

Conrad C, Niess H, Huss R, Huber S, von Luettichau I, Nelson PJ, Ott HC, Jauch KW, Bruns CJ.

Circulation. 2009 Jan 20;119(2):281-9. doi: 10.1161/CIRCULATIONAHA.108.793208. Epub 2008 Dec 31.

PMID:
19118255
33.

Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration.

Egaña JT, Fierro FA, Krüger S, Bornhäuser M, Huss R, Lavandero S, Machens HG.

Tissue Eng Part A. 2009 May;15(5):1191-200. doi: 10.1089/ten.tea.2008.0097.

PMID:
18925832
34.

TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.

Müller-Hermelink N, Braumüller H, Pichler B, Wieder T, Mailhammer R, Schaak K, Ghoreschi K, Yazdi A, Haubner R, Sander CA, Mocikat R, Schwaiger M, Förster I, Huss R, Weber WA, Kneilling M, Röcken M.

Cancer Cell. 2008 Jun;13(6):507-18. doi: 10.1016/j.ccr.2008.04.001.

35.

Isolation and characterization of adult stem cells from human salivary glands.

Rotter N, Oder J, Schlenke P, Lindner U, Böhrnsen F, Kramer J, Rohwedel J, Huss R, Brandau S, Wollenberg B, Lang S.

Stem Cells Dev. 2008 Jun;17(3):509-18. doi: 10.1089/scd.2007.0180.

PMID:
18522496
36.

Alkaline phosphatase, glutathione-S-transferase-P, and cofilin-1 distinguish multipotent mesenchymal stromal cell lines derived from the bone marrow versus peripheral blood.

Conrad C, Zeindl-Eberhart E, Moosmann S, Nelson PJ, Bruns CJ, Huss R.

Stem Cells Dev. 2008 Feb;17(1):23-7. doi: 10.1089/scd.2007.0159.

PMID:
18237266
37.

A complex pattern of chemokine receptor expression is seen in osteosarcoma.

von Luettichau I, Segerer S, Wechselberger A, Notohamiprodjo M, Nathrath M, Kremer M, Henger A, Djafarzadeh R, Burdach S, Huss R, Nelson PJ.

BMC Cancer. 2008 Jan 24;8:23. doi: 10.1186/1471-2407-8-23.

38.

[Cell-based strategies for salivary gland regeneration].

Rotter N, Wirz C, Oder J, Wollenberg B, Huss R, Brandau S, Lang S, Bücheler M.

HNO. 2008 Mar;56(3):281-7. doi: 10.1007/s00106-007-1650-5. Review. German.

PMID:
18210003
39.
40.

Genetically engineered stem cells for therapeutic gene delivery.

Conrad C, Gupta R, Mohan H, Niess H, Bruns CJ, Kopp R, von Luettichau I, Guba M, Heeschen C, Jauch KW, Huss R, Nelson PJ.

Curr Gene Ther. 2007 Aug;7(4):249-60. Review.

PMID:
17969558
41.

Broad, ectopic expression of the sperm protein PLCZ1 induces parthenogenesis and ovarian tumours in mice.

Yoshida N, Amanai M, Fukui T, Kajikawa E, Brahmajosyula M, Iwahori A, Nakano Y, Shoji S, Diebold J, Hessel H, Huss R, Perry AC.

Development. 2007 Nov;134(21):3941-52.

42.

Crosstalk between keratinocytes and adaptive immune cells in an IkappaBalpha protein-mediated inflammatory disease of the skin.

Rebholz B, Haase I, Eckelt B, Paxian S, Flaig MJ, Ghoreschi K, Nedospasov SA, Mailhammer R, Debey-Pascher S, Schultze JL, Weindl G, Förster I, Huss R, Stratis A, Ruzicka T, Röcken M, Pfeffer K, Schmid RM, Rupec RA.

Immunity. 2007 Aug;27(2):296-307. Epub 2007 Aug 9.

43.

Natural history and surgical treatment of brown tumor lesions at various sites in refractory primary hyperparathyroidism.

Khalil PN, Heining SM, Huss R, Ihrler S, Siebeck M, Hallfeldt K, Euler E, Mutschler W.

Eur J Med Res. 2007 May 29;12(5):222-30.

PMID:
17513195
44.

Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease.

Khalil PN, Weiler V, Nelson PJ, Khalil MN, Moosmann S, Mutschler WE, Siebeck M, Huss R.

Gastroenterology. 2007 Mar;132(3):944-54. Epub 2006 Dec 19.

PMID:
17383423
45.

Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.

Huber S, Bruns CJ, Schmid G, Hermann PC, Conrad C, Niess H, Huss R, Graeb C, Jauch KW, Heeschen C, Guba M.

Kidney Int. 2007 Apr;71(8):771-7. Epub 2007 Feb 14.

46.

Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging.

Zhang C, Wängler B, Morgenstern B, Zentgraf H, Eisenhut M, Untenecker H, Krüger R, Huss R, Seliger C, Semmler W, Kiessling F.

Langmuir. 2007 Jan 30;23(3):1427-34.

PMID:
17241069
47.

Stem cells and experimental leukemia can be distinguished by lipid raft protein composition.

Osterhues A, Liebmann S, Schmid M, Buk D, Huss R, Graeve L, Zeindl-Eberhart E.

Stem Cells Dev. 2006 Oct;15(5):677-86.

PMID:
17105403
48.

Industrial Pseudomonas folliculitis.

Hewitt DJ, Weeks DA, Millner GC, Huss RG.

Am J Ind Med. 2006 Nov;49(11):895-9.

PMID:
17036348
49.

Bone engineering: combining smart biomaterials and the application of stem cells.

Lechner S, Huss R.

Artif Organs. 2006 Oct;30(10):770-4.

PMID:
17026576
50.

Mononuclear infiltrates in osteosarcoma and chemokine receptor expression.

von Luettichau I, Nathrath M, Burdach S, Huss R, Segerer S, Nelson PJ.

Clin Cancer Res. 2006 Sep 1;12(17):5253-4; author reply 5254. No abstract available.

Supplemental Content

Support Center